MICHELLE PATERNOSTER FOUNDATION SARCOMA RESEARCH INC (EIN 465325065) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

PAUL PATERNOSTER

Phone

6315475470

Tax Period

2023-01-01 to 2023-12-31

MICHELLE PATERNOSTER FOUNDATION SARCOMA RESEARCH INC, founded in 2015, is a small nonprofit in the Diseases & Disorders sector that reported $167K in total revenue in fiscal year 2023. Revenue surged 81% from the prior year, signaling strong growth momentum. The organization ran a surplus of $48K, a strong 28% operating margin.

Mission

TO SUPPORT AND RESEARCH TOWARD FINDING A CURE FOR RHABDOMYOSARCOMA, A DEADLY FORM OF CANCER THAT AFFECTS CHILDREN AND YOUNG ADULTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $165,703

Program Service Revenue $0

Investment Income $1,192

Other Revenue $0

TOTAL REVENUE $166,895

Expense Breakdown

Grants Paid $116,500

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $116,500

Other Expenses $2,871

TOTAL EXPENSES $119,371

Year-over-Year Comparison

	2023	2022	Change
Revenue	$166,895	$92,271	+0.8%
Expenses	$119,371	$125,700	-0.1%
Net Income	$47,524	$-33,429	-2.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JAMES ROGERS	BOARD MEMBER	0.10	Director	$0	$0	$0
DUKE PATERNOSTER	BOARD MEMBER	0.10	Director	$0	$0	$0
JIM MCCORMACK	BOARD MEMBER	0.10	Director	$0	$0	$0
PAUL PATERNOSTER	PRESIDENT	1.00	Officer Director	$0	$0	$0
SCOTT PATERNOSTER	TREASURER	0.10	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$166,895	$119,371	$121,703	$47,524
2022	$92,271	$125,700	$74,179	$-33,429

MICHELLE PATERNOSTER FOUNDATION SARCOMA RESEARCH INC